article · Journal of Interventional Epidemiology and Public Health
Introduction: Hypertension remains a leading cause of cardiovascular disease globally. Tanzania reported 25% prevalence in 2020, but recent surveys indicate 30%-35%. This study determined hypertension prevalence and associated factors in the Tanga region to inform NCD interventions. Methods: A community-based cross-sectional survey used WHO STEPS methodology across Tanga City, Muheza, and Mkinga districts (N=1818). Data on demographics, lifestyle, family history, and antihypertensive use were collected via standardized questionnaire. Prevalence was calculated descriptively; modified Poisson regression estimated adjusted prevalence ratios (APR) with robust standard errors. Significance was P<0.05 (95% CI). Results: Hypertension prevalence was 37.7% (95%CI: 35.5-40.0%). Among hypertensives, 65.6% (450/686) were not aware of their hypertension status. In multivariable modified Poisson regression, older age increased hypertension risk: 45-54 years (APR= 2.07, 95%CI: 1.48-2.89), 55-64 years (APR =2.18, 95%CI: 1.54-3.07), and ≥65 years (APR= 3.00, 95%CI: 2.13-4.23) versus <25 years. Male sex (APR= 1.20, 95%CI: 1.05-1.37), urban residence (Muheza: APR= 1.24, 95%CI: 1.01-1.52; Tanga CC: APR= 1.47, 95%CI: 1.24-1.75), overweight (APR =1.62, 95%CI: 1.18-2.21), obesity (APR =1.79, 95%CI: 1.32-2.43), and family history (APR =1.13, 95%CI: 1.01-1.27) were significant risk factors. Physical exercise was protective (APR =0.89, 95%CI: 0.79-0.99). Conclusion: Hypertension prevalence exceeds national estimates, with poor screening and treatment adherence. Urban residence, male sex, advanced age, and obesity increase risk; exercise protects. Ministry of Health and its stakeholders must prioritise community screening, especially in urban areas, reinforce antihypertensive adherence through education, and promote physical activity to curb the NCD burden.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.37432/jieph-d-25-00121
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.